Rating: Neutral | Target price range: RMB 9.9-10.7 (base scenario fair value) | Current price: RMB 8.79 (close of 2026-10-28) | Margin of safety: +13% (base-case fair value floor of RMB 9.9 vs. current price of RMB 8.79) | Time horizon: 12-18 months | Total market cap approximately RMB 39.86 billion (calculated as closing price × total shares of 4.535 billion)
Timing note: The price anchor of this report is the 2026-10-28 closing price of RMB 8.79, at the low end of the 52-week range (RMB 8.78-11.82). The company disclosed its 2026 Q3 report after market close on that day (Juchao announcement date marked 10-29); the current price does not yet reflect the Q3 report information, and there is short-term gap repricing risk. All valuations in this report are based on that frozen closing price.
Zheshang Securities is a mid-sized full-licensed brokerage under Zhejiang Transportation Investment Group. After consolidating Guodu Securities in 2025, its total assets jumped to RMB 224.8 billion (+45.9%) and net profit attributable to the parent of RMB 2.412 billion hit a record high. For the first three quarters of 2026, net profit attributable to the parent reached RMB 2.286 billion (+20.8%), continuing strong growth, but the single third quarter weakened (revenue -25.1%, net profit attributable -9.2%), in sync with market-wide trading volumes retreating from mid-year peaks. The current price of RMB 8.79 corresponds to 1.04x PB(LF), the lowest decile in its own ten-year history, and book value per share of RMB 8.45 provides an asset-value floor close to the current price (-3.9% vs. current price); however, in cross-sectional comparison, the company's ROE (6.67% in 2025) lags major peers, and the sustainable ROE implied by the current price is about 8.6%-9.6%, above any realized year—"cheap" holds against its own history, but not against profitability and peer comparison. Probability-weighted fair value is approximately RMB 9.95 (+13.2% vs. current price); the odds structure is mildly positive but with limited magnitude. There are two core constraints: market trading volume contraction (October average daily turnover of about RMB 1.4-1.5 trillion, more than halved from the January-February peak) and the Guodu Securities integration plan remaining unsubmitted nearly 11 months past the regulatory approval deadline. Until both premises materialize (volume stabilization and recovery, and substantive integration progress), we maintain a neutral wait-and-see stance; a rise in the share price above RMB 10.7 or confirmation of either the volume or integration signal would be the primary trigger for adjusting our stance.
Nature of the opportunity: A high-beta brokerage stock at its lowest-ever valuation decile, with asset value near the current price providing downside support, waiting for direction amid dual uncertainties of "declining volumes not yet stabilized + pending M&A integration"—odds are mildly positive (weighted +13.2%), but conditions for action have not yet arrived.
Of the Q3 single-quarter attributable profit decline, about 4.5 percentage points came from non-recurring items—non-operating expenses of RMB 48.45 million (+4553.66% YoY, explained by the company as "increase in provisions for pending litigation"), while the volume-driven impact was concentrated on the revenue side: fair value change gains fell -44.03% YoY for the first three quarters (attributed by the company to "changes in financial instrument valuations due to securities market volatility"), and brokerage income slowed along with shrinking turnover. A distinction in scope is needed: margin financing balance was roughly flat YoY (about RMB 2.5 trillion in October 2025 vs. about RMB 2.5 trillion in October 2026); "volume contraction" mainly refers to sequential decline from the June 2026 peak rather than year-on-year deterioration. Full-year net profit attributable is estimated at RMB 2.75-2.93 billion based on a Q4 single quarter of RMB 460-640 million (YoY -12% to +23% against the 2025Q4 base of RMB 520 million), midpoint RMB 2.84 billion (+17.6%); 2027 growth depends on the volume center and Guodu synergies, with a neutral assumption of approximately RMB 3 billion magnitude.
A triple cross-sectional anchor shows the current price is not an industry-wide mispricing: the median PB of 5 regional comparables (Soochow 0.90/Yangtze 1.09/Caitong 0.90/Guoyuan 0.76/Xingye 0.84x) is about 0.90x, with the current price at a ~15.6% premium; the industry average PB is about 1.4x (lifted by large caps, as of 2026-09), against which the current price trades at a discount; and the entire industry is at low levels—4 of the 5 comparables have PB percentiles ≤9%, so the stock's low percentile reflects more sector beta than individual mispricing. Back-solving via the PB-ROE residual income framework, a 1.04x PB implies a sustainable ROE of about 8.6%-9.6% within an assumption range of 9.25% cost of equity and 0-5% perpetual growth, versus the company's realized 6.2%-6.7% over the past four years and about 7.3% on a TTM basis. The positive case for valuation repair to the base range (1.15-1.25x) rests on: its own trailing one-year median PB of about 1.20x, the precedent of sell-sides assigning a 1.2x target price to in-province peer Caitong Securities, and the M&A integration option—but these are all "option realization" rather than "realized profitability," which is precisely the valuation rationale for this report's neutral stance.
The dual nature of the integration is clear: consolidation directly drove total assets up 45.9% to RMB 224.8 billion, surpassing in-province peer Caitong Securities, and contributed RMB 245 million of attributable profit in 2025; but a 34.7692% stake means about 65% of Guodu's profit goes to minority shareholders (minority interests of RMB 10.584 billion at end-2026Q3, 21.6% of consolidated equity; minority interests' share of net profit was 13.1% for the first three quarters)—"scaling up" has not proportionally "thickened" earnings. Since Guodu's investment banking qualifications were suspended for 6 months in April 2023, no public disclosure of regulatory reinstatement was found within this report's search period, and its investment banking revenue has declined continuously (2025: -62.56%), corroborating that the business remains restricted. Integration completion and license restoration are one condition for ROE's center to rise toward 8% (the other is a sustained volume center), and a key variable for the goodwill impairment test on the RMB 682 million—if Guodu's profits keep declining or the integration remains long pending, goodwill impairment and a thematic discount will materialize simultaneously.
Zheshang+Guodu is one of the few cases of obtaining brokerage control with completed consolidation and board restructuring, positioning it favorably in the policy-endorsed M&A theme; if it raises its equity stake in Guodu via increased holdings or merger, based on Guodu's annual profit base and minority share, net profit attributable could be boosted by approximately RMB 280-480 million annually (the range depends on the year of Guodu's profit base and the path of stake increase, excluding share-swap dilution and consideration costs—about RMB 480 million at the upper bound of fully eliminating Guodu dilution, about RMB 280 million conservatively based on 2026 annualized minority interests), equivalent to 10%-17% of current attributable profit. In the opposite direction: head concentration keeps rising (listed brokers' profit CR10 already at 71.75%), commission rates are falling toward cost lines, and public fund fee reform's three phases cumulatively concede over RMB 50 billion annually—the medium-to-long-term ceiling for channel-type revenue is sinking. The M&A option coexisting with head-squeeze is the typical plight of mid-sized brokers.
Stress test: trading fixed income of about RMB 40.7 billion × duration 2.5 × 20bp rate rise ≈ -RMB 200 million; trading equities of about RMB 10.9 billion × 10% decline ≈ -RMB 1.09 billion; in the medium scenario, a single-quarter pre-tax impact of about -RMB 1.3 billion, 1.4x the Q3 total pre-tax profit (RMB 936 million)—one bad quarter can wipe out an entire quarter's profit; a 10% decline in the RMB 12 billion OCI high-dividend account would directly reduce net assets by about 3.1% (not through the income statement but eroding BVPS and dividend capacity). The bear case assumes volume shrinks to RMB 1.2-1.5 trillion daily and 2027 attributable profit falls back to the ~RMB 2 billion tier, pressing the valuation anchor toward 0.85-0.95x PB (based on expected end-2026 BPS of about RMB 8.55, translating to RMB 7.3-8.1); margin financing maintenance ratio of 330% has a thick buffer before the 130% margin-call line, so systemic forced-liquidation risk is limited—the real tail risk is the magnitude of earnings downgrades against 2026's high base.
| Metric | 2023FY | 2024FY (adjusted) | 2025FY | 2026Q1-Q3 (latest) |
|---|---|---|---|---|
| Operating revenue (RMB 100mn, net presentation basis) | 58.70 | 65.03 | 88.41 | 79.27 (+16.77%) |
| Net profit attributable to parent (RMB 100mn) | 17.54 | 19.32 | 24.12 | 22.86 (+20.82%) |
| Adjusted net profit attributable (RMB 100mn) | 17.42 | 19.12 | 23.88 | 23.01 (+23.25%) |
| Weighted ROE | 6.61% | 6.76% | 6.67% | 6.05% (nine months, not annualized) |
| Net margin (attributable/revenue) | 29.9% | 29.7% | 27.3% | 28.8% |
| Net operating cash flow (RMB 100mn) | 59.10 | 62.88 | -32.90 | 63.40 |
| Total assets (RMB 100mn, period end) | 1,455.28 | 1,540.86 | 2,248.14 | 2,558.21 |
| Net assets attributable to parent (RMB 100mn, period end) | 270.16 | 351.93 | 367.89 | 383.15 |
| Operating leverage (total assets/net assets attributable, x) | 5.39 | 4.38 | 6.11 | 6.68 |
| Bonds payable (RMB 100mn, period end) | — | 244.26 | 368.98 | 545.33 |
| Parent net capital (RMB 100mn, period end) | — | — | 258.10 | 292.75 |
Note: As a financial enterprise, industrially-oriented metrics such as gross margin, free cash flow, and net debt/EBITDA are not applicable and have been removed; industry substitute metrics (net capital, risk coverage ratio, margin financing balance) are in the "Industry Characteristics" chapter.
Reasons for metric changes (items with YoY ≥±20%): ① 2025 revenue +35.95%—management attributed this to net interest income +30.74%, net fee income +23.91%, and investment income +92.71% (proprietary business returns growth); ② 2025 operating cash flow -152.32% to -RMB 3.29 billion—management attributed this to "increase in net margin financing outstandings" (RMB 9.537 billion of margin financing deployment), a business-expansion outflow rather than deteriorating profit quality; it turned positive at +RMB 6.34 billion in the first three quarters of 2026 (client margin inflows); ③ total assets +45.90% in 2025—consolidation of Guodu Securities (adding RMB 38.123 billion) plus bond-funded balance sheet expansion (bonds payable of RMB 54.533 billion at end-2026Q3, +47.79% vs. start of year; company explanation: "new bond issuances in the period"); ④ other equity instrument investments of RMB 12.012 billion at end-2026Q3, +82.37% vs. start of year—company explanation: "increase in non-trading equity instruments," i.e., expansion of the high-dividend OCI strategy; ⑤ 2024 revenue retrospectively reduced by 59% (RMB 15.816bn → RMB 6.503bn)—the MOF implementation Q&A on standard warehouse receipt trading accounting required futures spot trading to switch to net presentation, a regulatory uniform requirement rather than discretionary accounting; net profit was unaffected.
First three quarters attributable profit of RMB 2.286 billion (+20.82%), adjusted RMB 2.301 billion (+23.25%); the foundation for a new full-year high is locked in. However, Q3 single-quarter revenue of RMB 2.224 billion (-25.11%) and attributable profit of RMB 675 million (-9.17%) mark the first negative-growth quarter since 2025. Breaking it down: ① about 4.5 percentage points of the single-quarter attributable decline came from pending litigation provisions (non-operating expenses of RMB 48.45 million, +4553.66%); the adjusted basis was only -4.70%, showing a significant one-off component; ② the real operating weakening is in proprietary trading—fair value change gains fell -44.03% YoY for the first three quarters (turning negative in Q3 alone), consistent with the shrinking, choppy equity market and low-rate bond environment in Q3; ③ brokerage and margin financing interest income slowed with the sequential decline in turnover, but the margin financing balance was flat YoY, so revenue-side resilience was better than headline revenue growth. The company marked the single-quarter changes as "not applicable" in the quarterly report without explanation. Overall judgment: Q3 is the superposition of three factors—"high base + sequential market volume decline + one-off provision"—not yet evidence of a trend-driven earnings downgrade, but it confirms results' high sensitivity to volume; the 2026Q4 base is low (2025Q4 attributable profit only RMB 520 million), so the probability of achieving RMB 2.75-2.93 billion for the full year remains high.
Business model in brief: A mid-sized, full-license securities broker where "brokerage + futures" forms the traffic base (in 2025, net fee and commission income accounted for 50.61% of revenue and net interest income 14.62%, together roughly 65% recurring revenue), with proprietary investment as the largest profit engine (investment income + fair-value changes at 34.00%) — a hybrid of asset-light intermediation and capital-heavy investment, with revenue sensitive to both market turnover and asset prices. After consolidating Guodu, the brokerage network expanded to Beijing, Shanghai, Guangzhou and Zhejiang; client assets reached RMB 1.2 trillion in 2026H1 (+46%).
Cash content of earnings (financial-institution basis; no CapEx/FCF/ROIC concepts): Operating cash flow swung widely between +5.91/+6.29/-3.29/+6.34 billion yuan, driven by margin financing deployment and client deposit inflows/outflows (RMB 9.5 billion of margin financing deployment alone explains the 2025 turn negative), and has nothing to do with earnings quality. Using alternative measures: ① the core variable of earnings quality is the proprietary return — financial investments grew from RMB 74.8 billion (end-2025) to 86.4 billion (end-2026Q3); the composite investment return ((investment income + fair-value changes)/average financial investments, our estimate) fell from ~4.81% in 2025 to ~4.32% annualized over the first three quarters of 2026; scale expansion offset the yield decline, meaning investment income growth relies on leverage-driven balance-sheet expansion; ② impairment provisions were modest overall (credit impairment + other asset impairment totaling ~RMB 123 million for the first three quarters, <2% of revenue, far below the routine provision needs implied by the margin financing scale — a bull-market characteristic); ③ net capital and risk-control buffers are ample (see the industry characteristics chapter), and expansion has not hit regulatory constraints.
Return on capital: Weighted ROE was 6.61%/6.76%/6.67% in 2023-2025, long below the average for listed brokers (8.04% in 2025) and the cost of equity — an industry-wide phenomenon (ROE<CoE in a low-rate environment), but the company also sits in the lower tier of its comparable group. Three paths to a higher ROE: a rising turnover center (brokerage + margin financing leverage), accretion from Guodu consolidation, and proprietary scale × yield — none of the first two has yet materialized.
Moat and warning signals: Moat = provincial SOE shareholder backing + density of Zhejiang's private-economy client base (trillion-level client assets) + licenses and branches acquired via M&A. Warnings: ① the profit engine relies heavily on directional proprietary trading (34% of revenue); under low bond yields the return center has already shifted down by about 0.5 percentage points; ② Guodu was consolidated but the company holds only 34.7692%, so roughly 65% of profit goes to minority shareholders, diluting attributable returns; ③ over the past five years the company has relied on convertible bonds + private placements to expand share capital (the 2024 forced conversion of converts added 696 million shares, +18% share capital), while the 2026 buyback and cancellation of 39 million shares (costing RMB 405 million, average price ~10.45 yuan/share) only partially offsets it — the historical "low ROE – refinancing – dilution" loop is a long-term valuation drag.
Consistency of words and deeds: pragmatic, no record of overstatement. Three verifiable promise-delivery pairs: ① the 2024 announced acquisition of Guodu Securities — transfer and consolidation plus board reshuffle completed in May 2025, contributing RMB 245 million of attributable profit that year (2025 annual report); ② "bond underwriting scale exceeding RMB 100 billion for three consecutive years" — 2025 bond principal underwriting of RMB 106.734 billion delivered (2025 annual report); ③ the 2025 annual report claims "record-high results" — attributable profit of RMB 2.412 billion, the highest since listing. Forward-looking statements in annual reports all carry "not an actual commitment" disclaimers. The sole negative: the Guodu integration plan has exceeded its filing deadline by nearly 11 months, with management's language ("refine and optimize, ensure on-time completion") now out of sync with the approval timetable.
Shareholder friendliness: neutral-to-positive. Payout ratios of 30.69%/35.21%/31.96% in 2023-2025; cumulative cash dividends of RMB 1.989 billion over the past three years; a two-dividend-per-year mechanism (interim + final) established from 2025 (2026 interim of RMB 0.08 per share, RMB 363 million in total, paid on October 30); completion in August 2026 of the cancellation of 38.78 million treasury shares (RMB 405 million). Offsetting factors: historical dilution from the 2021 RMB 2.8 billion private placement and 2024 forced conversion of converts (696 million shares) — the payout ratio is stable but insufficient to cover the pace of share-count expansion.
Risk signals: ① governance turnover — Wu Chenggen stepped down at end-2025, with Qian Wenhai becoming Chairman and legal representative; the chief accounting officer changed from Cheng Jingdong to Lou Min (per the 2026 interim report signature); ② regulatory measures three years in a row: CSRC order to rectify (investment banking quality-control and internal control deficiencies) in March 2025, Ningbo regulator warning letter (misleading sales of private funds at a branch) in July 2025, and on September 7, 2026, supervisory talks between the Zhejiang CSRC bureau and the company and its brokerage overseer ("inadequate compliance of brokers' practice, notable flaws in integrity-related internal controls," accountability report due within 30 days) — all soft measures with limited direct impact, but accumulation could affect the classification rating and qualifications for innovative business; ③ Zheshang Asset Management changed leadership in September 2026 (Lou Xiaoping becoming Chairman and General Manager).
| Business line | Revenue (RMB 100mn) | Share | Gross margin | YoY | Business logic in one line |
|---|---|---|---|---|---|
| Securities brokerage (incl. wealth management) | 51.41 | ~58% | 49.51% | +41.39% | Client assets topped RMB 1 trillion; volume and margin financing offset commission-rate pressure |
| Proprietary investment | 19.50 | ~22% | 73.67% | +69.75% | Directional revenue engine, main contributor to 2025 profit growth |
| Futures (Zheshang Futures) | 10.02 | ~11% | 36.66% | -4.73% | Brokerage + risk management; spot trading switched to net presentation |
| Investment banking | 7.51 | ~8% | 30.89% | +10.91% | Bonds strong, equities weak; #12 nationally in corporate bond underwriting; +55% in 2026H1 |
| Asset management (Zheshang AM) | 4.26 | ~5% | 21.00% | -19.66% | AUM of RMB 90.3 billion (-5.24%); bond-market redemptions and fee-rate declines weigh |
| Credit business (net interest income) | 12.93 | 14.62% | Not separately disclosed | +30.74% | Driven by margin balance rising from 32.8 to 40.5 billion yuan; a key profit driver |
Profit pillars: Brokerage (largest revenue base + 49.5% gross margin) and proprietary trading (73.7% gross margin) form the first tier; credit business (margin financing ramp) is the second engine — 2025 profit growth was mainly driven by proprietary (+69.75%) and credit (+30.74%). Gross-margin structure: proprietary (73.67%) vs. asset management (21.00%) differ by 52.7 percentage points — the former is a leveraged bet with own capital, the latter a pass-through business squeezed by both scale and fee rates; investment banking gross margin fell 2.95 percentage points, reflecting underwriting fee-rate wars. A notable divergence: 2026H1 investment banking revenue +55% (low-base recovery + IPO expansion) while asset management is still shrinking — the business mix is migrating from "asset management + futures" toward "investment banking + credit."
Current market data and percentiles: Price 8.79 yuan (2026-10-28 close), market cap ~RMB 39.86 billion (our estimate), PB(LF) 1.04x (0th percentile vs. its own 1/3/5/10-year history, per tool calculation), PB(2026E) ~1.03x, PE(TTM) 14.21x (earnings at a cyclical high; percentile for reference only). 2025 dividend yield ~1.93% (payout ratio 31.96%). For brokers, PB-ROE is the primary anchor; PE percentiles are mechanically low at an earnings peak and not treated as a headline signal.
Peer comparison (2025 annual report financials + 2026-10 valuations):
| Company | Attributable net profit (RMB 100mn) | Profit growth | ROE | PB | PE |
|---|---|---|---|---|---|
| Zheshang Securities | 24.12 | +24.9% | 6.67% | 1.04x | 14.2x |
| Soochow Securities | 35.52 | +50.1% | 8.36% | 0.90x | 9.7x |
| Changjiang Securities | 36.96 | +101.4% | 10.02% | 1.09x | 7.8x |
| Caitong Securities | 26.32 | +12.5% | 7.09% | 0.90x | 10.1x |
| Guoyuan Securities | 24.26 | +8.1% | 6.45% | 0.76x | 12.0x |
| Industrial Securities | 28.70 | +32.6% | 4.81% | 0.84x | 12.9x |
Zheshang's ROE is below Soochow/Changjiang/Caitong while its PB is above all comparables except Changjiang — the cross-sectional premium is mainly supported by an M&A option rather than profitability; the ~40% PE premium is partly a 2025 earnings-base difference (peers grew faster).
Market-implied expectations: At a 9.25% cost of equity and 0-5% perpetual growth, the 1.04x PB implies a sustainable ROE of ~8.6%-9.6%, equivalent to implied 2026E attributable profit of ~RMB 2.9-3.1 billion — i.e., the market prices in both "daily average turnover center holding/recovering above RMB 2 trillion" and "Guodu integration accretion" simultaneously. One-sentence judgment: at the current price the company must lift its sustainable ROE from 6.7% to ~9%, while the reality of the past four years is 6.2%-6.7%; before the double catalyst of turnover recovery and integration materializes, this expectation looks high.
Three-layer value: ① Asset value (floor) ≈ book value per share of 8.45 yuan (attributable net assets of RMB 38.3 billion, net capital of 29.275 billion supporting liquidation value), -3.9% from the current price — downside has a floor; ② EPV with zero growth (normalized earnings of RMB 2.59 billion from sustainable ROE 6.75% × net assets; FCFE ≈ attributable profit; cost of equity 9.25%) ≈ 6.17 yuan/share (range 5.8-6.6 yuan) — below the current price, reflecting the industry-wide ROE<CoE phenomenon; ③ growth option (current price − EPV) ≈ 2.6 yuan, ~30% of the price — the market's payment for Guodu integration synergies, further stake increases/M&A, and turnover recovery. The growth option share is not small (~30%); the current price is neither a deep mispricing paying "only for zero growth" nor pure narrative froth — whether the option deserves payment is answered by scenario math.
Three scenarios and odds (fair ranges based on PB-ROE, anchored independently of the current price: base case 1.15-1.25x anchored on its own one-year median of 1.20x and the precedent of same-province Caitong's 1.2x sell-side target, at a discount to the industry average of 1.4x; bear case 0.85-0.95x marked up from Guoyuan's 0.76x/Industrial's 0.84x; bull case 1.40-1.50x anchored on its own 2025 bull-market high of 1.48x):
| Scenario | Probability | Fair range (yuan) | vs. current | Key drivers |
|---|---|---|---|---|
| Bear | 30% | 7.3-8.1 | -17.0%~-7.8% | Turnover shrinks to daily RMB 1.2-1.5 trillion; 2027 attributable profit falls to ~RMB 2.0 billion; M&A synergies disproven |
| Base | 50% | 9.9-10.7 | +12.6%~+21.7% | Turnover moderately recovers to RMB 2.0-2.2 trillion center + partial Guodu synergy: 2026 attributable profit 2.84 billion, 2027 ~3.05 billion |
| Bull | 20% | 12.0-12.9 | +36.5%~+46.8% | M&A catalyst (stake increase/absorption of Guodu or new targets) + turnover above RMB 2.5 trillion: 2027 attributable profit 3.3-3.5 billion |
Probability-weighted fair value ≈ 9.95 yuan (+13.2%); the current price sits between the bear and base cases, closer to the bear side, with an asymmetric odds structure upward (+17.2% to base-case midpoint vs. -12.4% to bear-case midpoint). Our earnings forecast: 2026E revenue RMB 9.6-10.0 billion, attributable profit 2.75-2.93 billion (midpoint 2.84 billion, +17.6%; Q4 single quarter 460-640 million); 2027E revenue 10.1-10.7 billion, attributable profit 2.8-3.2 billion (midpoint 3.05 billion) — about 9% below sell-side consensus (3.12 billion, n=1), with the gap in Q4 turnover assumptions (we extrapolate from October conditions; the street implies Q4 +59.5%). Three-way comparison: management gives no quantitative guidance (qualitatively "stabilize the base, expand growth, optimize layout"), sell-side 3.12 billion, this report 2.84 billion — we will reconcile against this forecast at the next annual report.
Conclusion: Fair. Assess quality and price separately: quality is neutral-to-stable (ROE lags peers but regulatory capital is ample, regional client base is solid, M&A in progress); the price is at an absolute historical low versus its own past but not cheap versus peers, with elevated implied expectations; base-case fair value is 9.9-10.7 yuan, with the current price ~13% below the base-case floor (the positive margin of safety comes from a turnover-recovery option, not earnings mispricing). The price sits in the gap between the bear-case upper bound of 8.1 yuan and the base-case floor of 9.9 yuan, corresponding to a market in the intermediate state of "turnover decline confirmed, recovery unconfirmed." Target price range 9.9-10.7 yuan. Rating Neutral: odds lean positive but the two key premises (turnover, integration) remain unproven, and their realization depends on market conditions; waiting on the left side of the 52-week low for confirmation offers better odds than calling the inflection point.
Industry Size: China's securities industry (per the Securities Association of China, covering 150 brokers) posted 2025 operating revenue of RMB 541.171 billion and net profit of RMB 219.439 billion, both record highs since 2016 (2024: revenue RMB 438.0 billion, net profit RMB 159.8 billion; growth accelerated from +8.0%/+16.2% in 2024 to +19.95%/+31.2% in 2025); as of end-2025, total assets stood at RMB 14.83 trillion, net assets at RMB 3.34 trillion, and net capital at RMB 2.44 trillion. Market turnover is the master valve for industry revenue: A-share average daily turnover rose from ~RMB 1.06 trillion in 2024 → RMB 1.73 trillion in 2025 (+62.62%) → RMB 3.3 trillion in Jan-Feb 2026 (+89% YoY, cited by the Shanxi CSRC office) → RMB 2.32 trillion daily average in Q3 (+7.49%) → roughly RMB 1.4-1.5 trillion per day in late October; margin financing balance broke RMB 2.7 trillion in January 2026 → first crossed RMB 3.0 trillion on June 24 (record high) → fell back to ~RMB 2.5 trillion in late October. Equity financing has restarted: in the first three quarters of 2026, there were 122 A-share IPOs raising RMB 212.3 billion (+175% YoY, Deloitte China), versus 114 IPOs/RMB 129.6 billion for all of 2025. No systematic 3-5 year CAGR forecast exists for the industry; profits' heavy beta linkage to turnover/margin balance/index levels means "market size" is defined by market liquidity cycles rather than linear growth—this is the fundamental distinction between brokers and growth industries.
Industry Chain and Value Distribution: The brokerage industry has no traditional upstream; its core inputs are capital (net capital determines leverage and the ceiling for capital-intensive business), licenses, and talent. The five business lines differ sharply in profitability (2025 figures for 43 listed brokers, per BOC International Securities/iFinD): ① Proprietary investing RMB 225.8 billion (+30.31%), 40.88% of revenue, now the largest income source—the most profitable but with the largest beta volatility; industry annualized comprehensive investment yield was only 3.43%; ② Brokerage RMB 153.2 billion (+43.27%), 27.74% of revenue—volume up, price down, with average net commission rates falling to 0.02% amid channel commoditization, driving a shift toward service-fee income via fund distribution (RMB 13.477 billion, +51.95%); ③ Margin interest income RMB 86.9 billion (+19.97%)—scale-driven and homogeneous; ④ Investment banking RMB 39.9 billion (+30.05%), only 7.22% of revenue—equity underwriting CR5 at 64.82%, dominated by the top firms; ⑤ Asset management RMB 46.5 billion (+5.63%)—only 19 of 43 firms posted positive growth. Zheshang sits in the midstream full-license segment: fees + interest account for 65% (asset-light intermediary characteristics stronger than top-tier firms) and investment income 34%; profit pools lie in its Zhejiang branch network (client assets of RMB 1.2 trillion) and the Zheshang Asset Management/futures subsidiaries; bargaining power over upstream (funding) is weaker than top-tier firms (tiered bond issuance costs), while retail commissions are market-priced.
Supply, Demand, and Competitive Structure: Demand side = household wealth reallocation (client trading settlement funds of RMB 3.24 trillion; industry assets under custody of RMB 105.58 trillion, with falling deposit rates pushing money into equities) + surging trading volume + margin leverage demand + restart of equity financing. Supply side = 150 licensed brokers (licenses essentially frozen since 2016), with the number of players shrinking through M&A: Guotai Junan + Haitong (completed 2025, total assets of RMB 2.11 trillion, industry-leading), CICC absorbing Dongxing + China Xinda (settlement completed 2026-10-26, total assets above RMB 1 trillion), Guolian + Minsheng, and Soochow acquiring Donghai (under SSE review). Competitive structure: net profit attributable to parent CR5 47.23%/CR10 71.75% (2025, 43 listed brokers, iFinD/BOC International Securities); brokerage CR5 37.53%, investment banking revenue CR5 55.84%, IPO underwriting CR5 69.11%, asset management CR5 65.49%, proprietary investing CR5 46.99%. Entry barriers = licenses + net capital + talent + regional client bases; M&A has become the main route to acquiring licenses and branch networks (precisely the logic behind Zheshang + Guodu and Guolian + Minsheng). The industry structure is a barbell of "aggregate oversupply + head-end scarcity": channel businesses are oversupplied with normalized price wars (commission rates at 0.02%, three-phase public fund fee reforms conceding over RMB 50 billion annually in cumulative fee cuts), while top-tier investment banking licenses and capital remain structurally scarce. Substitution threats: internet brokers and third-party platforms siphoning retail commissions; bank wealth management products, public funds, and private funds diverting wealth management demand. Mid-sized brokers survive through regional depth and differentiated niche businesses, while being squeezed from both ends—unable to compete with head firms in institutional and international business, and losing share to emerging players (East Money's low-cost channel). This squeeze from both sides is the structural position of firms like Zheshang.
Cycles and Regulation: The industry is in a cooling phase of "profit boom at high levels + trading heat retreating from peaks": the 2025 ROE of 43 listed brokers was 8.04% (+185bp), a multi-year high, but 2026 volume has been front-loaded (June peak → near 14-month lows by October), and the Shanghai Composite has drawn down over 13% from its May high of 4,258; the sector's P/B (1.14x as of May 2026 per BOC, below the 10th percentile of the past decade) has compressed further with share prices. Leading indicators: average daily turnover, margin balance, IPO acceptance/approval pace, sector P/B percentile, and M&A approval progress. The regulatory stance is neutral-to-positive: the "world-class investment banks" blueprint (2-3 international investment banks by 2035) plus Wu Qing's 2026-10-19 Financial Street Forum remarks on "supporting M&A restructuring and subsequent integration" directly benefit mid-sized brokers with completed deals; the three-phase public fund fee reform (final phase effective 2026-01-01, overall fee cuts of ~RMB 30 billion/34%) and new programmatic trading rules (2025-07-07) compress channel revenue and raise compliance costs; IPO expansion (regulators stating "new listings won't surge; supply and demand are relatively balanced") is mildly positive for investment banking. Net assessment: policy benefits concentrate on brokers with "M&A narratives + wealth management transformation," while pure-channel small and mid-sized brokers face headwinds—Zheshang belongs to the former group.
Company's Position in the Industry: A Zhejiang provincial state-owned mid-sized full-service broker, in the "first tier of mid-sized brokers + regional wealth management leader," leaping from a regional broker to a national mid-sized one via the Guodu acquisition. Hard metrics (2025): total assets of RMB 224.814 billion (+45.90% post-consolidation, with Guodu contributing ~24.7% of the increment), surpassing provincial peer Caitong (~RMB 160 billion range); net profit attributable to parent of RMB 2.412 billion, ranking roughly 19th among 43 listed brokers, with weighted ROE of 6.67% ranking roughly 23rd—the scale tier exceeds the profitability tier; the scale dividend from the acquisition has not yet translated into earning power. Share trends are on an upward path: wealth management—2026H1 stock and fund trading volume of RMB 6.95 trillion (+75%), faster than the overall market, with client assets at RMB 1.2 trillion (+46%); investment banking—IPO underwriting scale jumped to 11th in the industry (combined basis). Moat sources = provincial state-owned backing + density of Zhejiang's private-economy client base + license and network expansion through M&A integration; weaknesses = ROE below same-tier peers and high dependence on market beta. The provincial duopoly with Caitong is the best case study for regional competition: Caitong pursues an endogenous "funds + asset management" route (steady growth), while Zheshang pursues "brokerage/wealth management + M&A expansion" (scale leap but unresolved integration)—the valuation divergence between the two routes (P/B 1.04 vs 0.90) is precisely the market's pricing disagreement over the M&A path.
Two decisive dimensions distinguishing brokers from general industries are easily missed by generic frameworks and are therefore treated separately.
(1) Volume Transmission Chain—the Common Input to All Revenue. Market liquidity (turnover + margin balance) simultaneously drives the company's three major revenue lines: ① Turnover → brokerage commissions + fund distribution (2026H1 stock and fund trading volume of RMB 6.95 trillion, +75%, driving brokerage revenue growth); ② Margin balance → net interest income (company margin balance of RMB 40.5 billion, market share 1.342% (end-2026H1, vs. 1.292% at end-2025), with rates pressured by funding costs); ③ Equity index and bond market trends → proprietary investment returns (directional exposure within RMB 86.4 billion of financial investments). The 2026 empirical record: the H1 volume peak corresponded to revenue +49.33%, while the Q3 volume retreat corresponded to a single-quarter -25.11%—volume is the single largest earnings variable, and the company's own operational alpha (market share, fee rate management) explains only second-order differences. Sensitivity magnitude: if average daily turnover falls from RMB 2.3 trillion to RMB 1.5 trillion (-35%), linear extrapolation based on brokerage revenue share and market share implies brokerage-line revenue contracting by roughly 30%; with linked contraction in margin interest and proprietary income, the annualized volume elasticity of net profit attributable to parent is roughly 20-30%—this is the basis for the bear-case derivation (2027 net profit in the RMB 2.0 billion range). Conversely, volume recovering above a RMB 2 trillion central level is a necessary condition for the base case.
(2) Regulatory Capital Constraints—the Hard Ceiling and Safety Cushion on Balance Sheet Expansion. Broker balance sheet expansion is hard-constrained by net capital risk-control metrics. At end-2026Q3, the parent company's net capital was RMB 29.275 billion (+13.4% from RMB 25.810 billion at the start of the year), risk coverage ratio 345.84% (regulatory floor 100%), capital leverage ratio 19.70% (≥8%), liquidity coverage ratio 271.94% (≥100%), net stable funding ratio 163.96% (≥100%), proprietary equity assets/net capital 28.11%, proprietary non-equity assets/net capital 161.69%—all metrics have ample headroom, meaning current leveraged expansion (total assets +13.8% YTD to RMB 255.8 billion; bonds payable +47.8% to RMB 54.5 billion) remains far below regulatory limits, and supply elasticity in capital-intensive business is intact; net capital/net assets of 85.57% is also above typical peer levels. This is both an opportunity (large expansion room when volume recovers) and a risk (expansion dilutes returns in a low-ROE environment). Tracking metric: a tightening of quarterly disclosed risk-control ratios (risk coverage ratio approaching 200%) would be a leading signal that the expansion thesis has ended.
(3) Beta Stratification of Revenue Structure: Recurring income (brokerage commissions + interest, ~65%) moves linearly with volume, while directional income (proprietary investing, ~34%) moves nonlinearly with asset prices—the latter is an amplifier of earnings volatility (+65.91% in 2025 driving record profit; -63.8% in the single quarter of 2026Q3 dragging results negative). The OCI high-dividend strategy added through Guodu consolidation (other equity instrument investments expanding to RMB 12 billion over two years) is a structural attempt to smooth directional volatility in a low-rate environment, at the cost of decoupling the income statement from actual investment gains and losses (see "Financial Engineering and Cross-Period Consistency"). Sector beta is roughly 1.3-1.5: in the index stabilization and recovery phase, brokerage stocks outperform the index; the current combination of 52-week lows + 0th percentile P/B means "low position, high beta"—the upside elasticity after direction is confirmed is as significant as the continued downside risk if direction is misjudged.
Overall Rating: Neutral (confidence 0.55, 12-18 month horizon). At the current price of RMB 8.79, the downside protection comes from "asset value floor (book value per share of RMB 8.45, -3.9% below current price) + the company's own decade-low P/B percentile + dense policy catalysts," plus option value from a "probability-weighted +13.2% with asymmetric odds skewed upward"; however, ROE lags peers, the implied ROE of ~8.6%-9.6% at current prices exceeds any realized year, and neither prerequisite—market volume nor integration—has been delivered. Until confirmation signals appear, neutral observation is preferable to left-side positioning. Strategically: RMB 8.79 is not a good selling point (asset value lies just below), but it is not a sufficient buying point either. Average daily turnover sustaining above RMB 1.5 trillion + margin balance recovering above RMB 2.6 trillion, or announcement of a finalized Guodu integration plan, are the two confirmation signals for turning positive.
Risk and Catalyst Alerts: Downside risks ranked by importance—persistent volume contraction (R1, high), double-hit on proprietary directional exposure (R3, medium-high), Guodu integration limbo and goodwill impairment (R4, medium-high), pending litigation payouts (R5, medium), refinancing dilution cycle (R6, low-medium). Upside catalysts—2026 annual results setting new highs (March-April 2027), brokerage M&A policy implementation and Guodu integration plan (2026Q4-2027Q2), RRR cuts and volume recovery (2026Q4-2027Q1), restoration of Guodu's investment banking licenses (within 2027), a new round of cancellation buybacks (unconfirmed). Margin credit impairments (maintenance ratio steady at 330%) and cumulative regulatory actions are secondary tracking items.
Data sources: Zheshang Securities 2024/2025 annual reports and Q1/Q2/Q3 2026 quarterly reports (cninfo); Guodu Securities 2026 semi-annual report; Securities Association of China; BOC International Securities' "Securities Industry 2025 Annual Report Review"; Deloitte China IPO statistics; Shanxi CSRC office; public reports from Cailian Press, 21st Century Business Herald, Securities Daily, China Securities Journal, and others; valuation percentiles and market data are as of the 2026-10-28 close. This report is for research and analysis only and does not constitute investment advice.